The Cover

Gene expression arrays were performed in 21 patients having surgery for malignant pleural mesothelioma. Twentyseven significant genes common to both dChip and SAM analyses from the original set of 95 genes depicted here were able to define two groups of patients whose time to progression and survival were significantly different. For details, see H. I. Pass et al., in this issue.